A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

Princeton received fewer awards in the past two fiscal years of 2023 and 2024 than in every year since 2011 and less funding ...

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story NIH pauses grant-making processThe ...

Researchers at Harvard’s Longwood medical campus contended with canceled talks and blocked international collaboration as ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...